ScreenerHero

ELABPMGC Holdings Inc.

NAS · US · Healthcare · Biotechnology · pmgcholdings.com
6.660USD+1088.65%Mkt Cap: 5.39M $P/E: —

PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT pac…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap5.39M $
Enterprise Value384.50K $
Revenue (TTM)2.58M $
Gross Profit185.31K $
Net Income (TTM)-7.75M $
Revenue/Share1.908 USD
Last Price6.660 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.03
EV/Revenue0.15
P/S0.19
P/B0.22
EPS (TTM)-1993.37
EPS (Forward)—
52W Range
0.54002% of range309.89
52W High309.89 USD
52W Low0.5400 USD
Profitability
Gross Margin31.40%
Oper. Margin-289.98%
EBITDA Margin0.00%
Profit Margin-1313.00%
ROE-98.86%
ROA-60.21%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.93M $
CapEx (TTM)448.25K $
FCF Margin-172.61%
FCF Yield-82.55%
Net Debt-4.55M $
Net Debt/EBITDA0.39
Balance Sheet
Debt/Equity0.34
Current Ratio1.36
Quick Ratio1.26
Book Value/Sh2.720 USD
Cash/Share2.321 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateAug 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.809.58K
Float7.29M
Insiders5.61%
Institutions3.29%
Short Interest
Short Ratio0.1d
Short % Float7.16%
Short % Out.7.16%
Shares Short44.04K
Short (prev mo.)33.11K
Technical
SMA 5010.77 (-38.1%)
SMA 200207.44 (-96.8%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)2.08M
Avg Vol (10d)45.98K
Technical Indicators
RSI (14)91.6
MACD0.3650
MACD Signal-0.0064
MACD Hist.+0.3714
BB Upper3.772 USD
BB Middle1.192 USD
BB Lower-1.3883 USD
BB Width432.99%
ATR (14)0.5647 USD
Vol Ratio (20d)0.41x